Post by Octapharma

With haematology at the heart of our business, we are committed to advancing care for patients living with secondary immunodeficiency associated with haematological malignancies.​ ​ Join us at the #EHA2026 Congress at Stockholmsmässan in Sweden this weekend, where we look forward to connecting with the global haematology community and exploring the latest clinical advancements. Explore our latest research at EHA2026​: https://lnkd.in/e2MqtX39 The event is for HCPs only.